STZ
57
2
DE
56
10
BAX
30
4
GWW
71
4
PEG
67
5
HP
45
4
AMZN
55
-3
WU
30
6
EMC
53
5
EXPE
91
3
BSX
70
2
CPB
24
2
CTSH
54
-2
MAS
56
5
NAVI
47
3
MTCH
42
5
BRK.B
42
2
MAR
65
2
HBI
55
-4
FE
52
3
STZ
57
2
DE
56
10
BAX
30
4
GWW
71
4
PEG
67
5
HP
45
4
AMZN
55
-3
WU
30
6
EMC
53
5
EXPE
91
3
BSX
70
2
CPB
24
2
CTSH
54
-2
MAS
56
5
NAVI
47
3
MTCH
42
5
BRK.B
42
2
MAR
65
2
HBI
55
-4
FE
52
3
Financhill
Back

Arcutis Biotherapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
10.13
Seasonality Move:
101.78%
Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
450.53
Seasonality Move:
11.1%
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.24. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $450.37. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $450.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 57.11 Buy
Chaikin Money Flow: -531506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.48 - 10.2) Buy
Bollinger Bands (100): (8.98 - 10.48) Buy

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.97 Sell
Relative Strength Index (14 RSI): 37.76 Sell
Chaikin Money Flow: 44374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (462.09 - 494.97) Sell
Bollinger Bands (100): (465.11 - 492.19) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.98 Buy
20-day SMA: 9.57 Buy
50-day SMA: 9.6 Buy
200-day SMA: 9.48 Buy
8-day EMA: 10 Buy
20-day EMA: 9.76 Buy
50-day EMA: 9.63 Buy
200-day EMA: 9.15 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 468.86 Sell
20-day SMA: 479.26 Sell
50-day SMA: 474.44 Sell
200-day SMA: 453.81 Sell
8-day EMA: 465.05 Sell
20-day EMA: 474.27 Sell
50-day EMA: 475.71 Sell
200-day EMA: 452.67 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.54 per share, and an increase next year of $18.39 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):